The Discovery of Kisqali
®
(Ribociclib): A
CDK
4/6 Inhibitor for the Treatment of
HR
+/
HER
2− Advanced Breast Cancer
Successful Drug Discovery（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined